Blockade of STAT3 activation inhibits the glycolytic flux and decreases in PFKFB3 and HK2 expression in RA monocytes resulting in metabolic reprogramming and resolution of inflammation [118]. The gene discussed is STAT3; the disease is rheumatoid arthritis.